![](/img/cover-not-exists.png)
Phase 1 study of MEDI0562, a humanized OX40 agonist monoclonal antibody (mAb), in adult patients (pts) with advanced solid tumors
Glisson, B.S., Leidner, R., Ferris, R.L., Powderly, J., Rizvi, N., Norton, J.D., Burton, J., Lanasa, M.C., Patel, S.P.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw378.07
Date:
October, 2016
File:
PDF, 40 KB
english, 2016